LUNG
USDPulmonx Corporation Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$1.790
고가
$1.790
저가
$1.660
거래량
0.89M
기업 기본 정보
시가총액
69.4M
산업
의료 기기
국가
United States
거래 통계
평균 거래량
2.37M
거래소
NMS
통화
USD
52주 범위
AI 분석 리포트
마지막 업데이트: 2025년 10월 31일LUNG (Pulmonx Corporation) Market Analysis: Undervalued MedTech with Mixed Signals
Quick Overview
Pulmonx (LUNG) trades at $2.03 as of October 31, 2025, with a negative P/E ratio (-1.27) and small market cap ($82.6M). Recent analyst upgrades and a management shakeup dominate headlines, while technical indicators show caution. Fundamental scores suggest potential value, but debt and weak equity returns weigh down long-term confidence.
Key News Sentiment
- Analyst Optimism Amid Lower Targets
- Lake Street and D. Boral Capital kept "Buy" ratings but slashed price targets (from $8 → $4 and $16 → $14).
- Why it matters: Analysts see long
관련 뉴스
Lake Street Maintains Buy on Pulmonx, Lowers Price Target to $4
Lake Street analyst Frank Takkinen maintains Pulmonx with a Buy and lowers the price target from $8 to $4.
D. Boral Capital Maintains Buy on Pulmonx, Lowers Price Target to $14
D. Boral Capital analyst Jason Kolbert maintains Pulmonx with a Buy and lowers the price target from $16 to $14.
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Officer, appointed
AI 예측Beta
AI 추천
업데이트 시간: 2025년 11월 4일 오후 06:55
61.4% 신뢰도
리스크 & 트레이딩
진입점
$1.81
익절
$2.06
손절
$1.66
핵심 요소
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기